St. Vincent’s Healthcare Group (SVHG) UCD Translational Medicine Symposium

18th June 2018

Friday 8th June marked the St. Vincent’s Healthcare Group (SVHG) UCD Translational Medicine Symposium which took place at the Research Centre in St. Vincent’s University Hospital (SVUH).

This one day, CPD accredited Symposium covered an impressive array of expert clinical speakers on medical research innovations ranging from; colorectal cancer, multiple sclerosis, rheumatoid Arthritis and on obesity.

Some ground breaking internationally peer reviewed research presentations focused on;

· High dimensional immune phenotyping of inflammatory bowel disease patients, the key to better predictive biomarkers and alternative treatment strategies – Dr. Liz Ryan, Senior Scientist, Centre for Colorectal Disease, SVUH

·  Body Composition Change During Chemotherapy for Borderline Resectable Pancreatic Cancer – Ms. Oonagh Griffin, Oncology Dietitian, SVHG

·  Sharing Research Leadership with Patients – Prof. Rachel Crowley, ucd Associate Clinical Professor and Consultant Endocrinologist SVUH

·  HIV and Co-morbidities- focus on cardiovascular disease – Prof. Paddy Mallon, Associate Dean Research and Innovation UCD and  HIV Molecular Group

·   The Impact of Obesity on Obesity – Prof. Donal O’Shea, Consultant Endocronologist and HSE Clinical Lead for Obesity.

Speaking at the conference, Prof. Peter Doran, Director of Research at SVHG said:

“The UCD SVHG Translational Medicine Symposium emphasises the overall scope of the research programme being delivered here in St. Vincent’s Healthcare Group. The Symposium is a platform for showcasing the excellence in science happening right here on our campus. As Director of Research for SVHG, I am very proud of the high impact research (as gauged by international peer reviewed outputs) that is being delivered by leading clinicians here in Dublin and across our three hospitals in SVHG.”

Also speaking at the conference, Prof. Michael Keane, Group Clinical Director for SVHG said:

“I believe that this innovative Translational Medicine Symposium is an important opportunity to demonstrate the broad scientific profile of research activity that is continuously undertaken by our hospital group in conjunction with our academic partner UCD. Our academically acclaimed clinicians are at the forefront of modern medical research and scientific innovation on an international level. This scientific innovation was clearly reflected in the programme of presentations delivered covering advances in modern medicine for example in; cancer treatment and in immunology.”

Over 100 clinical and nursing staff attended this CPD accredited Symposium.